Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,534 | 39 | 172 | N/A | N/A |
| Other current assets | 0 | 751 | 325 | 170 | 30 |
| TOTAL | $5,534 | $790 | $497 | $170 | $30 |
| Non-Current Assets | |||||
| PPE Net | 5 | 8 | 12 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 80 | 690 |
| TOTAL | $5 | $8 | $12 | $80 | $690 |
| Total Assets | $5,539 | $798 | $509 | $250 | $720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,662 | 2,715 | 1,225 | 620 | 270 |
| Accrued Expenses | 521 | 163 | 15 | 650 | 490 |
| Other current liabilities | 2,347 | 5,054 | 3,258 | 180 | 150 |
| TOTAL | $4,627 | $24,714 | $6,148 | $3,300 | $1,540 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100 | 100 | 11,919 | 0 | 0 |
| TOTAL | $100 | $100 | $11,919 | $590 | $N/A |
| Total Liabilities | $4,727 | $24,814 | $18,066 | $3,890 | $1,540 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,664 | N/A | N/A | N/A | N/A |
| Common Shares | 21 | 5 | 5 | 120 | 120 |
| Retained earnings | -40,404 | -29,518 | -21,602 | N/A | N/A |
| Other shareholders' equity | 6,050 | 0 | 0 | 0 | 6 |
| TOTAL | $812 | $-24,016 | $-17,557 | $45,880 | $45,826 |
| Total Liabilities And Equity | $5,539 | $798 | $509 | $49,770 | $47,366 |